Groundbreaking Jab Reverses Alzheimer's in Mice, Human Trials Next
A groundbreaking injection has shown promising results in reversing Alzheimer's disease in mice. The injection repairs the blood-brain barrier, allowing the body to clear toxic proteins naturally. Human trials could begin within the next few years.
Alzheimer's disease, affecting over 600,000 people in Britain, is the leading cause of dementia. The condition causes the blood-brain barrier to malfunction, allowing toxic proteins to build up uncontrollably. Scientists have discovered an injection that can reverse this process in mice. The injection works by helping the LRP1 protein to grab toxins more efficiently, reducing amyloid-beta amounts in the brain by 50 to 60 percent within an hour. Remarkably, one mouse treated with the injection recovered to behave like a younger, healthier mouse within six months.
The injection, which could soon be effective in humans, offers hope for a breakthrough in Alzheimer's treatment. Human trials are expected to begin in the next few years, marking a significant step towards understanding and combating this devastating condition.
